NEWS
Our Latest News
ARCHIMED acquires Jeisys Medical, a leading developer of aesthetic medicine devices
ARCHIMED initiates the delisting from Korea Exchange of shares in Jeisys Medical, a leading developer of aesthetic medicine devices, after acquiring Jeisys Medical via change-of-control transactions, including public tenders.
ARCHIMED buys Stragen Pharma, a leader in the development, registration and distribution of hard-to-make generic drugs
June
24,
2021
ARCHIMED’s Fytexia buys B Natural, the European leader in the extraction and refinement of compounds produced by bees
June
1,
2021
ARCHIMED’s Direct Healthcare Group buys United Care BV
March
24,
2021
ARCHIMED’s Direct Healthcare Group acquires Talley
March
3,
2021
Acquisition by ARCHIMED’s NAMSA makes it the preeminent contract research organization for medtech lab testing
March
2,
2021
ARCHIMED strengthens its North American capabilities
January
26,
2021
368